The amendment corrects multiple formatting and numbering errors in the bill—fixing hyphenation in chemical names (like "levo-alpha-acetylmethadol"), correcting item numbering from duplicates to sequential entries (38-59), and standardizing line breaks in chemical compound names—without changing the substantive list of Schedule I controlled substances being added. This is a technical cleanup that NARROWS the changes to formatting/presentation only, keeping the bill's core purpose intact.
26.767.11 26.767.12 101st Legislative Session 1162 2026 South Dakota Legislature House Bill 1162 Introduced by: Representative Hunt Underscores indicate new language. Overstrikes indicate deleted language. ENROLLED AN ACT ENTITLED An Act to add certain substances to Schedule I of the controlled substances 1 schedule. 2 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA: 3 Section 1. That § 34-20B-12 be AMENDED: 4 34-20B-12. Any of the following substances, including their isomers, esters, 5 ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless 6 specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is 7 possible within the specific chemical designation: 8 (1) Acetylmethadol; 9 (2) Allylprodine; 10 (3) Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-11 acetylmethadol, levo-alpha-acetylmethadol, levomethadyl acetate or LAAM; 12 (4) Alphameprodine; 13 (5) Alphamethadol; 14 (6) Benzethidine; 15 (7) Betacetylmethadol; 16 (8) Betameprodine; 17 (9) Betamethadol; 18 (10) Betaprodine; 19 (11) Clonitazene; 20 (12) Dextromoramide; 21 (13) Diampromide; 22 (14) Diethyliambutene; 23 (15) Dimenoxadol; 24 (16) Dimepheptanol; 25 (17) Dimethyliambutene; 26 26.767.11 26.767.12 2 1162 Underscores indicate new language. Overstrikes indicate deleted language. HB1162 ENROLLED (18) Dioxaphetyl butyrate; 1 (19) Dipipanone; 2 (20) Ethylmethylthiambutene; 3 (21) Etonitazene; 4 (22) Etoxeridine; 5 (23) Fenethylline; 6 (24) Furethidine; 7 (25) Hydroxypethidine; 8 (26) Ketobemidone; 9 (27) Levomoramide; 10 (28) Levophenacylmorphan; 11 (29) Mecloqualone; 12 (30) Morpheridine; 13 (31) Noracymethadol; 14 (32) Norlevorphanol; 15 (33) Normethadone; 16 (34) Norpipanone; 17 (35) Phenadoxone; 18 (36) Phenampromide; 19 (37) Phenibut; 20 (38) Phenomorphan; 21 (38)(39) (39) Phenoperidine; 22 (39)(40) (40) Piritramide; 23 (40)(41) (41) Proheptazine; 24 (41)(42) (42) Properidine; 25 (42)(43) (43) Racemoramide; 26 (43)(44) (44) Tianeptine; 27 (45) Trimeperidine; 28 (44)(46) (46) Methaqualone; 29 (45)(47) (47) N-benzylpiperazine; 30 (46)(48) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-31 benzenesulfonamide, (48) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide, W-18; 32 (47)(49) (49) N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-33 1-amine, isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, also known as isotonitazene; 34 26.767.11 26.767.12 3 1162 Underscores indicate new language. Overstrikes indicate deleted language. (48)(50) 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-1 amine HB1162 ENROLLED (50) 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene); 2 (49)(51) (51) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine 3 (etodesnitazene, etazene); 4 (50)(52) N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-5 amine) (52) N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene); 6 (51)(53) (53) N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine 7 (metodesnitazene); 8 (52)(54) N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-9 amine (54) N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (metonitazene); 10 (53)(55) (55) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (N-11 pyrrolidino (N-pyrrolidino etonitazene, etonitazepyne); 12 (54)(56) N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-13 amine (56) N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene); 14 (55)(57) (57) 7-[(10,11-dihydro-5 H -dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) 15 (amineptine); 16 (56)(58) (58) N-phenyl-N′ -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-17 yl)carbamimidate) -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) (mesocarb); and 18 (57)(59) (59) N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine). 19 26.767.12 4 1162 HB1162 ENROLLED An Act to add certain substances to Schedule I of the controlled substances schedule. I certify that the attached Act originated in the: House as Bill No. 1162 Chief Clerk of the House Speaker of the House Attest: Chief Clerk of the House President of the Senate Attest: Secretary of the Senate House Bill No. 1162 File No. ____ Chapter No. ______ Received at this Executive Office this _____ day of _____________, 2026 at ____________M. By for the Governor The attached Act is hereby approved this ________ day of ______________, A.D., 2026 Governor STATE OF SOUTH DAKOTA, ss. Office of the Secretary of State Filed ____________, 2026 at _________ o'clock __M. Secretary of State By Asst. Secretary of State